← Open Payments lookup

MEGAN PERRY: Open Payments

NPI 1811762016 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$420 in 18 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $538 · 2025 $420

Food & beverage: $420
CompanyPaymentsAmount
Regeneron Healthcare Solutions, Inc.5$154
GlaxoSmithKline, LLC.4$81
Optinose US, Inc.3$60
Genentech USA, Inc.2$48
ALK-Abello, Inc1$25
ARS Pharmaceuticals Operations, Inc.1$22
Agios Pharmaceuticals, Inc.1$15
AstraZeneca Pharmaceuticals LP1$15

Products named: DUPIXENT, NUCALA, Xhance, Xolair, Grastek, NEFFY, PYRUKYND, BREZTRI.

Industry payments across VA — which companies pay providers there.